Global Health Limited (MEDANTA) - Total Assets
Based on the latest financial reports, Global Health Limited (MEDANTA) holds total assets worth Rs59.05 Billion INR (≈ $638.60 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Global Health Limited reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Global Health Limited - Total Assets Trend (2018–2026)
This chart illustrates how Global Health Limited's total assets have evolved over time, based on quarterly financial data. Check MEDANTA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Global Health Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Global Health Limited's total assets of Rs59.05 Billion consist of 28.4% current assets and 71.6% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 19.1% |
| Accounts Receivable | Rs4.11 Billion | 7.0% |
| Inventory | Rs789.83 Million | 1.3% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs162.03 Million | 0.3% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2018–2026)
This chart illustrates how Global Health Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Global Health Limited market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Global Health Limited's current assets represent 28.4% of total assets in 2026, an increase from 23.8% in 2018.
- Cash Position: Cash and equivalents constituted 19.1% of total assets in 2026, up from 2.4% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 7.0% of total assets.
Global Health Limited Competitors by Total Assets
Key competitors of Global Health Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Aier Eye Hospital Group
SHE:300015
|
China | CN¥36.58 Billion |
|
PACS Group, Inc.
NYSE:PACS
|
USA | $5.66 Billion |
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.50 Billion |
|
Compass Pathways Plc
NASDAQ:CMPS
|
USA | $210.35 Million |
|
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
|
China | CN¥8.17 Billion |
|
RHÖN-KLINIKUM Aktiengesellschaft
XETRA:RHK
|
Germany | €1.86 Billion |
|
Metro Healthcare Indonesia
JK:CARE
|
Indonesia | Rp4.19 Trillion |
|
MLP Saglik Hizmetleri AS
IS:MPARK
|
Turkey | TL89.94 Billion |
Global Health Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.67 | 2.48 | 1.94 |
| Quick Ratio | 2.54 | 2.37 | 1.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs10.48 Billion | Rs9.14 Billion | Rs3.92 Billion |
Global Health Limited - Advanced Valuation Insights
This section examines the relationship between Global Health Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.31 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 23.9% |
| Total Assets | Rs59.05 Billion |
| Market Capitalization | $3.66 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Global Health Limited's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Global Health Limited's assets grew by 23.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Global Health Limited (2018–2026)
The table below shows the annual total assets of Global Health Limited from 2018 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs59.05 Billion ≈ $638.60 Million |
+23.89% |
| 2025-03-31 | Rs47.66 Billion ≈ $515.45 Million |
+10.74% |
| 2024-03-31 | Rs43.04 Billion ≈ $465.47 Million |
+4.57% |
| 2023-03-31 | Rs41.16 Billion ≈ $445.13 Million |
+30.85% |
| 2022-03-31 | Rs31.46 Billion ≈ $340.18 Million |
+16.76% |
| 2021-03-31 | Rs26.94 Billion ≈ $291.36 Million |
+1.04% |
| 2020-03-31 | Rs26.66 Billion ≈ $288.35 Million |
+7.75% |
| 2019-03-31 | Rs24.74 Billion ≈ $267.60 Million |
+24.73% |
| 2018-03-31 | Rs19.84 Billion ≈ $214.54 Million |
-- |
About Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emerg… Read more